2024 Chinese Expert Consensus Guidelines on the Diagnosis and Treatment of Atrial Fibrillation in the Elderly, Endorsed by Geriatric Society of Chinese Medical Association (Cardiovascular Group) and Chinese Society of Geriatric Health Medicine (Cardiovascular branch): Executive Summary
执笔作者机构：[1]Department of Cardiology, Second Medical Center, National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing100853, China[2]Pulmonary Vessel and Thrombotic Disease, Sixth Medical Center, Chinese PLA General Hospital, Beijing100048, China[3]Department of Geriatrics, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China[4]Beijing Taikang Yanyuan Rehabilitation Hospital, Beijing 102299, China[5]Arrhythmia Center, Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing 100021, China[6]Geriatric Center, West China Hospital, Sichuan University, Chengdu 610044, China[7]Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom[8]Danish Center for Health Services Research, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
The consensus guidelines of the Geriatric Society of Chinese Medical Association (GSCMA) on the management of atrial fibrillation (AF) in the elderly was first published in 2011 and updated in 2016, with endorsement by Chinese Society of Geriatric Health Medicine (CSGHM). Since then, many important studies regarding the screening and treatment in the elderly population have been reported, necessitating this updated expert consensus guidelines. The writing committee members comprehensively reviewed updated evidence pertaining to elderly patients with AF, and formulated this 2024 update. The highlighted issues focused on the following: screening for AF, geriatric comprehensive assessment, use of the Atrial fibrillation Better Care (ABC) pathway for the elderly patients, and special clinical settings related to elderly patients with AF. New recommendations addressing smart technology facilitated AF screening, ABC pathway based management and optimal anticoagulation were developed, with a focus on the elderly.The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
基金：
The study was supported by Beijing Natural Science Foundation (L232117) ，National Natural
Science Foundation of China (82170309).
Wang Yutang
（Department of Cardiology, Second Medical Center, National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing100853, China）
Guo Yutao
（Pulmonary Vessel and Thrombotic Disease, Sixth Medical Center, Chinese PLA General Hospital, Beijing100048, China）
Qin Mingzhao
（Department of Geriatrics, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China）
Fan Jin
（Beijing Taikang Yanyuan Rehabilitation Hospital, Beijing 102299, China）
Tang Ming
（Arrhythmia Center, Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing 100021, China）
Zhang Xinjun
（Geriatric Center, West China Hospital, Sichuan University, Chengdu 610044, China）
Wang Hao
（Department of Cardiology, Second Medical Center, National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing100853, China）
Li Xiaoying
（Department of Cardiology, Second Medical Center, National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing100853, China）
Lip Gregory Yh
（Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom;Danish Center for Health Services Research, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark）
Xiaoming Wang
（Department of Geriatrics, Xijing Hospital, Air Force Military University, Xi’an 710032,China）
Jingfeng Wang
（Department of Cardiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China）
Xuejun Ren
（Cardiology Center, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China）
Wei Hua
（Arrhythmia Center, Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing 100021, China）
Xiangming Shi
（Department of Arrhythmia, Sixth Medical Center, Chinese PLA General Hospital, Beijing100048, China）
Liqun Wu
（Department of Cardiology, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200040, China）
Cuntai Zhang
（Department of Integrative Medicine, Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology, Wuhan 430073, China）
Shu Zhang
（Arrhythmia Center, Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing 100021, China）
Xuhua Chen
（Arrhythmia Center, Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing 100021, China）
Xiping Tuo
（Department of Geriatrics, Changhai Hospital, Naval Medical University, Shanghai 200082, China）
Zhaoliang Shan
（Department of Arrhythmia, Sixth Medical Center, Chinese PLA General Hospital, Beijing100048, China）
Shan Yu
（Department of Cardiology, Guizhou Provincial People's Hospital, Guiyang 550499, China）
Lang Hong
（Jiangxi Provincial Cardiovascular Disease Hospital, Jiangxi Provincial People's Hospital, Nanchang 330006, China）
Yuquan He
（Department of Cardiology, The Bethune Third Hospital of Jilin University, Jilin 130033, China）
Yiqiang Yuan
（Henan Provincial Chest Hospital, Chest Hospital of Zhengzhou University, Zhengzhou 450008, China）
Xiang Gu
（Department of Cardiology, Northern Jiangsu People's Hospital, Affiliated Hospital to Yangzhou University, Clinical Medical School of Nanjing Medical University, Yangzhou 225001, China）
Congxin Huang
（Institute of cardiovascular Disease, Renmin Hospital of Wuhan University, Wuhan 430060, China）
Dejia Huang
（Department of Cardiology, West China Hospital, Sichuan University, Chengdu 610044, China）
Kejiang Cao
（Department of Cardiology, Department of Geriatrics, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029 , China）
本院专家组成员：
Qin Mingzhao[3]
（Department of Geriatrics, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China）
Wang Yutang,Guo Yutao,Qin Mingzhao,et al.2024 Chinese Expert Consensus Guidelines on the Diagnosis and Treatment of Atrial Fibrillation in the Elderly, Endorsed by Geriatric Society of Chinese Medical Association (Cardiovascular Group) and Chinese Society of Geriatric Health Medicine (Cardiovascular branch): Executive Summary[J].Thrombosis And Haemostasis.2024,
APA：
Wang Yutang,Guo Yutao,Qin Mingzhao,Fan Jin,Tang Ming...&Kejiang Cao.(2024).2024 Chinese Expert Consensus Guidelines on the Diagnosis and Treatment of Atrial Fibrillation in the Elderly, Endorsed by Geriatric Society of Chinese Medical Association (Cardiovascular Group) and Chinese Society of Geriatric Health Medicine (Cardiovascular branch): Executive Summary.Thrombosis And Haemostasis,,
MLA：
Wang Yutang,et al."2024 Chinese Expert Consensus Guidelines on the Diagnosis and Treatment of Atrial Fibrillation in the Elderly, Endorsed by Geriatric Society of Chinese Medical Association (Cardiovascular Group) and Chinese Society of Geriatric Health Medicine (Cardiovascular branch): Executive Summary".Thrombosis And Haemostasis .(2024)
医学